Rabeprazole sodium

• CAT Number: I000638
• CAS Number: 117976-90-6
• Molecular Formula: C18H21N3O3S • Na
• Molecular Weight: 382.42
• Purity: ≥95%
• Synonyms: sodium 2-(((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methyl)sulfinyl)benzo[d]imidazol-1-ide
• Target: Apoptosis
• Solubility: DMSO 48 mg/ml
• Storage: -20°C
• IUPAC Name: sodium;2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]benzimidazol-1-ide
• InChI: InChI=1S/C18H20N3O3S.Na/c1-13-16(19-9-8-17(13)24-11-5-10-23-2)12-25(22)18-20-14-6-3-4-7-15(14)21-18;/h3-4,6-9H,5,10-12H2,1-2H3;/q-1;+1
• InChIKey: KRCQSTCYZUOBHN-UHFFFAOYSA-N
• SMILES: CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3[N-]2)OCCCOC.[Na+]

Rabeprazole sodium (Cat No.:I000638) is a medication belonging to the class of drugs known as proton pump inhibitors (PPIs). It is primarily used for the treatment of ulcers in the stomach and duodenum, as well as gastroesophageal reflux disease (GERD). Rabeprazole sodium works by reducing the production of stomach acid, thereby helping to alleviate symptoms and promote the healing of ulcers. It is commonly prescribed for short-term treatment and maintenance therapy in patients with acid-related disorders, providing relief and improving overall gastrointestinal health.